Back to top

Stemline Therapeutics (STML) Soars: Stock Up 39.5%

Read MoreHide Full Article
Stemline Therapeutics, Inc. (STML - Free Report) was a big mover last session, as its shares rose almost 40% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $19.08 to $21.09.

In the last 30 days, the company did not witness any estimate revision, while the Zacks Consensus Estimate moved higher. Friday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Stemline currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Other better-ranked stocks in the medical sector include Gentium S.p.A , Emergent BioSolutions, Inc. (EBS - Free Report) and Actelion Ltd. . All three sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Stemline Therapeutics, Inc. (STML) - free report >>

Emergent Biosolutions Inc. (EBS) - free report >>

More from Zacks Tale of the Tape

You May Like